TRGP:NYSETarga Resources, Inc. Analysis
Data as of 2026-03-10 - not real-time
$234.74
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Targa Resources is trading well above its 20‑day, 50‑day and 200‑day moving averages, with the price sitting near $235 and a bullish trend direction, while the RSI hovers around the mid‑60s indicating upward momentum. Technical momentum is supported by a solid support level around $210 and a resistance ceiling near $250, though the MACD histogram has turned negative, hinting at a potential short‑term pullback. Volatility is elevated at roughly 24% over the past 30 days, and beta is close to 1, suggesting the stock moves in line with the broader market.
Fundamentally, the company posted a revenue decline of about 8% year‑over‑year, yet delivered a 20% jump in EBITDA and announced a $5.5 billion capex plan for 2026. The dividend of $1.00 per share (1.7% yield) is backed by a 44% payout ratio, but the balance sheet is heavily leveraged with a debt‑to‑equity ratio exceeding 500%, and free cash flow remains negative. Valuation metrics—PE of 27.6 versus an industry average of 20.6 and a DCF fair value far below the current price—signal that the stock is priced on the high side, despite a strong “strong buy” analyst consensus and an outlook for record earnings.
Fundamentally, the company posted a revenue decline of about 8% year‑over‑year, yet delivered a 20% jump in EBITDA and announced a $5.5 billion capex plan for 2026. The dividend of $1.00 per share (1.7% yield) is backed by a 44% payout ratio, but the balance sheet is heavily leveraged with a debt‑to‑equity ratio exceeding 500%, and free cash flow remains negative. Valuation metrics—PE of 27.6 versus an industry average of 20.6 and a DCF fair value far below the current price—signal that the stock is priced on the high side, despite a strong “strong buy” analyst consensus and an outlook for record earnings.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above key moving averages and strong technical momentum
- Attractive dividend yield with sustainable payout
- Upcoming earnings beat and capex‑driven growth
Medium Term
1–3 yearsNeutral
Model confidence: 8/10
Key Factors
- Projected EBITDA growth and record 2026 outlook
- High leverage and overvalued multiples
- Potential for price correction toward fair value
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable cash‑flow generation from midstream operations
- Continued dividend income supporting total return
- Elevated debt levels and valuation premium requiring caution
Key Metrics & Analysis
Financial Health
Revenue Growth-7.90%
Profit Margin11.29%
P/E Ratio27.6
ROE51.38%
ROA8.68%
Debt/Equity548.63
P/B Ratio16.4
Op. Cash Flow$3.9B
Free Cash Flow$-264400000
Industry P/E20.6
Technical Analysis
TrendBullish
RSI64.8
Support$209.60
Resistance$250.00
MA 20$230.23
MA 50$205.60
MA 200$176.43
MACDBearish
VolumeStable
Fear & Greed Index79.75
Valuation
Fair Value$95.49
Target Price$242.45
Upside/Downside3.28%
GradeOvervalued
TypeGrowth
Dividend Yield1.70%
Risk Assessment
Beta0.97
Volatility23.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.